Mechanism of inhibition of cathepsin K by potent, selective 1,5-diacylcarbohydrazides: A new class of mechanism-based inhibitors of thiol proteases

被引:27
作者
Bossard, MJ
Tomaszek, TA
Levy, MA
Ijames, CF
Huddleston, MJ
Briand, J
Thompson, S
Halpert, S
Veber, DF
Carr, SA
Meek, TD
Tew, DG
机构
[1] SmithKline Beecham Pharmaceut, Dept Mol Recognit, King Of Prussia, PA 19406 USA
[2] SmithKline Beecham Pharmaceut, Dept Phys & Struct Chem, King Of Prussia, PA 19406 USA
[3] SmithKline Beecham Pharmaceut, Dept Med Chem, King Of Prussia, PA 19406 USA
关键词
D O I
10.1021/bi991193+
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nature of the inhibition of thiol proteases by a new class of mechanism-based inhibitors, 1,5-diacylcarbohydrazides, is described. These potent, time-dependent, active-site spanning inhibitors include compounds that are selective for cathepsin K, a cysteine protease unique to osteoclasts. The 1,5- diacylcarbohydrazides are slow substrates for members of the papain superfamily with inhibition resulting from slow enzyme decarbamylation. Enzyme-catalyzed hydrolysis of 2,2'-N,N'-bis (benzyloxycarbonyl)-L-leucinylcarbohydrazide is accompanied by formation of a hydrazide-containing product and a carbamyl-enzyme intermediate that is sufficiently stable to be observed by mass spectrometry and NMR. Stopped-flow studies yield a saturation limited value of 43 s(-1) for the rate of cathepsin K acylation by 2,2'-N,N'-bis (benzyloxycarbonyl)-L-leucinylcarbohydrazide. Inhibition potency varies among pro teases tested as reflected by 2-3 orders of magnitude differences in K-i and k(obs)/I, but all eventually form the same stable covalent intermediate. Reactivation rates are equivalent for all enzymes tested (1 x 10(-4) s(-1)), indicating hydrolysis of a common carbamyl-enzyme form. NMR spectroscopic studies with cathepsin K and 2,2'-N,N'-bis(benzyloxycarbonyl)-L-leucinylcarbohydrazide provide evidence of inhibitor cleavage to generate a covalent carbamyl-enzyme intermediate rather than a tetrahedral complex. The product Cbz-Leuhydrazide does not appear enzyme-bound after cleavage in the NMR spectra, suggesting that the stable inhibited form of the enzyme is the thioester complex. I,5-Diacylcarbohydrazides represent a new class of unreactive cysteine protease inhibitors that share a common mechanism of action across members of the papain superfamily. Both S and S' subsite interactions are exploited in achieving high selectivity and potency.
引用
收藏
页码:15893 / 15902
页数:10
相关论文
共 32 条
[21]  
LERNER UH, 1992, J BONE MINER RES, V7, P433
[22]   Conformationally constrained 1,3-diamino ketones: A series of potent inhibitors of the cysteine protease cathepsin K [J].
Marquis, RW ;
Yamashita, DS ;
Ru, Y ;
LoCastro, SM ;
Oh, HJ ;
Erhard, KF ;
DesJarlais, RL ;
Head, MS ;
Smith, WW ;
Zhao, BG ;
Janson, CA ;
Abdel-Meguid, SS ;
Tomaszek, TA ;
Levy, MA ;
Veber, DF .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (19) :3563-3567
[23]   Crystal structure of human cathepsin K complexed with a potent inhibitor [J].
McGrath, ME ;
Klaus, JL ;
Barnes, MG ;
Bromme, D .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (02) :105-109
[24]  
MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201
[25]  
RICH DH, 1998, PROTEINASE INHIBITOR, P153
[26]   ON SIZE OF ACTIVE SITE IN PROTEASES .I. PAPAIN [J].
SCHECHTER, I ;
BERGER, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1967, 27 (02) :157-+
[27]   Design of potent and selective human cathepsin K inhibitors that span the active site [J].
Thompson, SK ;
Halbert, SM ;
Bossard, MJ ;
Tomaszek, TA ;
Levy, MA ;
Zhao, BG ;
Smith, WW ;
Abdel-Meguid, SS ;
Janson, CA ;
D'Alessio, KJ ;
McQueney, MS ;
Amegadzie, BY ;
Hanning, CR ;
DesJarlais, RL ;
Briand, J ;
Sarkar, SK ;
Huddleston, MJ ;
Ijames, CF ;
Carr, SA ;
Garnes, KT ;
Shu, A ;
Heys, JR ;
Bradbeer, J ;
Zembryki, D ;
Lee-Rykaczewski, L ;
James, IE ;
Lark, MW ;
Drake, FH ;
Gowen, M ;
Gleason, JG ;
Veber, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14249-14254
[28]   Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo [J].
Votta, BJ ;
Levy, MA ;
Badger, A ;
Bradbeer, J ;
Dodds, RA ;
James, IE ;
Thompson, S ;
Bossard, MJ ;
Carr, T ;
Connor, JR ;
Tomaszek, TA ;
Szewczuk, L ;
Drake, FH ;
Veber, DF ;
Gowen, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (09) :1396-1406
[29]  
Williams J W, 1979, Methods Enzymol, V63, P437
[30]   Structure and design of potent and selective cathepsin K inhibitors [J].
Yamashita, DS ;
Smith, WW ;
Zhao, BG ;
Janson, CA ;
Tomaszek, TA ;
Bossard, MJ ;
Levy, MA ;
Oh, HJ ;
Carr, TJ ;
Thompson, SK ;
Ijames, CF ;
Carr, SA ;
McQueney, M ;
DAlessio, KJ ;
Amegadzie, BY ;
Hanning, CR ;
AbdelMeguid, S ;
DesJarlais, RL ;
Gleason, JG ;
Veber, DF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (46) :11351-11352